EraGen Biosciences has hired Mark Meyers and Mary Holland as vice presidents of sales and marketing. In his new position, Meyers will build partnerships around EraGen’s Master Catalog platform, an interpretive proteomics system based on an evolutionary analysis of protein families. It can be used to determine model organisms and for drug target identification. Before joining EraGen, Meyers was vice president of sales for Scimagix.
Meantime, in her new position, Holland will be responsible for EraGen’s Aegis synthetic DNA platform. Before joining EraGen, Holland was the senior director of worldwide corporate accounts for Nanogen.